We’re proud to offer decades of experience in observational and non-interventional research studies. This allows us to be fully adaptive when realising your product’s value.
Accelerated approvals and regulatory pressure to mitigate risk make it especially important to demonstrate drug safety post-approval, effectiveness, and utilisation patterns under real life conditions. Observational research enables long-term evaluation in these areas and generates evidence to define, substantiate and communicate the value of your treatment to different stakeholders.
Our treatment value experts understand the varied needs of patients, payers and healthcare professionals. We’ll help you demonstrate the value of your treatment for these audience by identifying the actions needed to maximise the potential of your treatment before and after approval, and minimise the possible risks.
Also within Health
Data and Analytics
Clinical Research & Medical Affairs